ArticleWhat's the best way to monitor low-risk patients with a history of differentiated thyroid cancer?Author:Angela M. Albrecht, MDPublish date: December 1, 2009Evidence-based answer: A recombinant human thyrotropin (rhTSH)-stimulated serum thyroglobulin (Tg) level alone is sufficient to monitor for recurre...Read More
